Ahumanrez Neuro Pharma Private Limited
Founded in 2018 and headquartered in Rajasthan, India.
2018 | Jaipur, Rajasthan (India) | Active
Ahumanrez Neuro Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 400.54%
- Ebitda 2341.23%
- Net Worth 43.12%
- Total Assets 123.47%
About Ahumanrez Neuro Pharma
Ahumanrez Neuro Pharma Private Limited (ANPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 2018 (Six years and two months 11 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devendra Kumar and Shahruna Bano serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999RJ2018PTC063382
- Company No.
063382
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Business Services
Who are the key members and board of directors at Ahumanrez Neuro Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendra Kumar  | Director | 20-Dec-2018 | Current |
| Shahruna Bano | Additional Director | 03-Jul-2023 | Current |
Financial Performance of Ahumanrez Neuro Pharma.
Ahumanrez Neuro Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 400.54% increase in profit. The company's net worth Soared by an impressive increase of 43.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ahumanrez Neuro Pharma?
Unlock access to Ahumanrez Neuro Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Neomediq India (Opc) Private Limited
Devendra Kumar is a mutual person
- Mainsern India Private Limited
Devendra Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ahumanrez Neuro Pharma?
Unlock and access historical data on people associated with Ahumanrez Neuro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ahumanrez Neuro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ahumanrez Neuro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
